Posted on 6/9/16
Three Ogilvy CommonHealth Worldwide Creatives Appointed to Judge CLIO Health Awards
Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com), and a WPP company (NASDAQ:WPPGY) (www.wpp.com), announced Diane Iler-Smith, EVP, chief creative . . .
Posted on 6/9/16
Johnson & Johnson (JNJ) Presents at 2016 Goldman Sachs 37th Annual Global Healthcare Conference (Transcript)
Johnson & Johnson (NYSE:JNJ)Goldman Sachs 37th Annual Global Healthcare ConferenceJune 8, 2016 12:20 PM ETExecutivesLouise Mehrotra - Vice President, Investor RelationsDominic Caruso - Executive Vice President . . .
Posted on 6/9/16
Celgene (CELG) Presents at Goldman Sachs Healthcare Brokers Conference (Transcript)
Celgene Corporation (NASDAQ:CELG)Goldman Sachs Healthcare ConferenceJune 08, 2016, 12:00 PM ETExecutivesJacqualyn Fouse - President and COOAnalystsTerence Flynn - Goldman SachsLisa Hayes - Senior Director, IRREAD FULL . . .
Posted on 6/8/16
Cantel Medical Announces Record Financial Results for Third Quarter 2016
CANTEL MEDICAL CORP. (NYSE: CMN) today reported US GAAP net income of $14,019,000, or $0.34 per diluted share, on a 22.8% increase in sales to a . . .
Posted on 6/8/16
Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship
Beckman Coulter, Inc., a global developer and manufacturer of clinical diagnostic products, and Ortho Clinical Diagnostics (Ortho), a global in vitro diagnostics leader, today announced a . . .
Posted on 6/8/16
DaVita Announces Intent to Enter into Transaction with Inspira Health Network
DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA), today announced its intent to enter into a joint venture acquisition with Inspira Health Network . . .
Posted on 6/8/16
Twelve Genesis HealthCare Centers Receive Bronze National Quality Award
Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that 12 of its Centers have been recognized as 2016 recipients of the . . .
Posted on 6/8/16
Certara and the FDA Extend Their Partnership
PRINCETON, N.J.--(BUSINESS WIRE)--Certara®, the global biosimulation technology-enabled drug development company, today announced that the US Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine has extended . . .
Posted on 6/8/16
These Drug Stocks Just Disappointed Investors -- Are They Buys?
IMAGE SOURCE: GETTY IMAGES.Developing game-changing treatments isn't easy. Often drug developers fall short in their efforts and when they do, investors can overreact and send shares . . .
Posted on 6/8/16
3 Biotech Stocks Billionaires Are Buying That I'm Buying, Too
IMAGE SOURCE: FLICKR USER STOCKMONKEYS.COM.Billionaire investors have proven that they can profit in good and bad times, and while no one should blindly follow in the . . .
Posted on 6/8/16
Legal Dispute Puts Ionis Pharmaceuticals' Payday on Hold
IMAGE SOURCE: IONIS PHARMACEUTICALS, INC.A spat between Merck & Co. (NYSE:MRK) and Gilead Sciences (NASDAQ:GILD) that could have a big impact on Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) . . .
Posted on 6/8/16
Why Celldex Therapeutics, Inc. Stock Rose 14.5% in May
What: Shares of Celldex Therapeutics (NASDAQ:CLDX), a clinical-stage biotech developing targeted cancer therapies, gained 14.5% last month, according to data from S&P Global Market Intelligence. Bargain . . .
Posted on 6/7/16
Better Dividend Stock: Pfizer vs. Amgen
Pfizer (NYSE:PFE) and Amgen (NASDAQ:AMGN) both reported great Q1 2016 results, which, combined with their juicy dividends (Pfizer's is around 3.5%, while Amgen's yields around 2.5%), . . .
Posted on 6/7/16
Johnson & Johnson Courting Huge Revenue Potential In Multiple Myeloma Space
The management of multiple myeloma has grown increasingly crowded in recent years, with dramatic implications for patient benefit. One leader in this space is Johnson and . . .
Posted on 6/7/16
Reproductive Medicine Associates of New Jersey Opens New Office in Marlton, NJ
On July 5, Reproductive Medicine Associates of New Jersey (RMANJ), a world-renowned leader in the field of infertility, will welcome patients to its newest location inMarlton, . . .
Posted on 6/6/16
Why Anacor Pharmaceuticals, Inc. Stock Jumped 58.3% in May
What: Shares of Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), a biopharmaceutical company discovering, developing, and commercializing novel small-molecule therapeutics, shot up 58.3% last month, according to data from . . .
Posted on 6/6/16
Better Buy: Eli Lilly and Company vs. Pfizer
After years of sliding revenue, both Eli Lilly and Company (NYSE:LLY) and Pfizer(NYSE:PFE) are finally seeing their top lines slope upward. Longtime shareholders are pleased by . . .
Posted on 6/6/16
Why Celator Pharmaceuticals Shares Skyrocketed 100% in May
IMAGE SOURCE: CELATOR PHARMACEUTICALS.What: After reporting late-stage trial results that clear the way to an FDA approval and announcing that it has agreed to be acquired . . .
Posted on 6/6/16
Fitness App WeTrain Wants to Democratize Personal Training
If you can order a pizza through an app, shouldn’t you also be able to order a personal trainer? In October 2015, Jon Sockol
Posted on 6/5/16
ACT Oncology Is Now Precision Oncology
ACT Oncology, the leading contract research organization (CRO) specializing exclusively in the field of oncology, has changed its name to Precision Oncology (precisionforoncology.com). The new name . . .
Posted on 6/3/16
Attention Merck Investors: It's Time to Start Worrying
Merck (NYSE:MRK), like many of its Big Pharma brethren, is angling to find ways to grow following an extended period of patent expirations sapping its ability . . .
Posted on 6/2/16
5 Billionaires Just Bought 3.3 Million Shares of Celldex Therapeutics
Clinical-stage biotech Celldex Therapeutics' (NASDAQ:CLDX) stock was clobbered during the general sell-off that affected its entire industry to start the year. Then, in early April, its . . .
Posted on 6/2/16
Onconova Files S-1 Registration Statement for Rights Offering to Shareholders
NEWTOWN, Pa., June 01, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to . . .
Posted on 6/1/16
Better Buy: Celldex Therapeutics, Inc. vs. Ionis Pharmaceuticals, Inc.
Biotech stocks haven't performed very well over the past 12 months. A couple of them have seen downright dismal results. Shareholders of Celldex Therapeutics, Inc. (NASDAQ:CLDX)have . . .
Philadelphia
